4//SEC Filing
Lang Daniel 4
Accession 0001209191-22-042900
CIK 0001300699other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 5:28 PM ET
Size
10.5 KB
Accession
0001209191-22-042900
Insider Transaction Report
Form 4
Athenex, Inc.ATNX
Lang Daniel
Pres Cell Therapy, VP Corp Dev
Transactions
- Award
Stock Option (Right to Buy)
2022-07-20+200,000→ 200,000 totalExercise: $0.67Exp: 2032-07-20→ Common Stock (200,000 underlying)
Holdings
- 40,000
Stock Option (Right to Buy)
Exercise: $10.25Exp: 2030-08-27→ Common Stock (40,000 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $2.77Exp: 2031-09-16→ Common Stock (50,000 underlying) - 50,000
Restricted Stock Units
→ Common Stock (50,000 underlying) - 73,413
Common Stock
Footnotes (6)
- [F1]Includes 30,000 shares subject to a restricted stock award vesting in four equal annual installments beginning on August 26, 2020.
- [F2]This option vests in four equal annual installments beginning on August 27, 2021.
- [F3]This option vests in four equal annual installments beginning on September 16, 2022.
- [F4]Each restricted stock unit represents a contingent right to receive one share of stock.
- [F5]The restricted stock units vest in four equal annual installments beginning on September 16, 2022.
- [F6]This option vests in four equal annual installments beginning on July 20, 2023.
Documents
Issuer
Athenex, Inc.
CIK 0001300699
Entity typeother
Related Parties
1- filerCIK 0001895384
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 5:28 PM ET
- Size
- 10.5 KB